330 related articles for article (PubMed ID: 32202738)
1. [The frequency of formation of a motivated refusal to take androgenic anabolic steroids by men with recreational activity].
Lykhonosov MP; Babenko AY; Makarin VA; Fedotov YN
Probl Endokrinol (Mosk); 2019 Nov; 65(5):341-350. PubMed ID: 32202738
[TBL] [Abstract][Full Text] [Related]
2. Effects of Anabolic Androgenic Steroids on the Reproductive System of Athletes and Recreational Users: A Systematic Review and Meta-Analysis.
Christou MA; Christou PA; Markozannes G; Tsatsoulis A; Mastorakos G; Tigas S
Sports Med; 2017 Sep; 47(9):1869-1883. PubMed ID: 28258581
[TBL] [Abstract][Full Text] [Related]
3. Prolonged hypogonadism in males following withdrawal from anabolic-androgenic steroids: an under-recognized problem.
Kanayama G; Hudson JI; DeLuca J; Isaacs S; Baggish A; Weiner R; Bhasin S; Pope HG
Addiction; 2015 May; 110(5):823-31. PubMed ID: 25598171
[TBL] [Abstract][Full Text] [Related]
4. The use of post-cycle therapy is associated with reduced withdrawal symptoms from anabolic-androgenic steroid use: a survey of 470 men.
Grant B; Kean J; Vali N; Campbell J; Maden L; Bijral P; Dhillo WS; McVeigh J; Quinton R; Jayasena CN
Subst Abuse Treat Prev Policy; 2023 Nov; 18(1):66. PubMed ID: 37951896
[TBL] [Abstract][Full Text] [Related]
5. Anabolic androgenic steroid-induced hypogonadism, a reversible condition in male individuals? A systematic review.
Vilar Neto JO; da Silva CA; Bruno da Silva CA; Pinto DV; Caminha JSR; de Matos RS; Nunes Filho JCC; Alves FR; Magalhães SC; De Francesco Daher E
Andrologia; 2021 Aug; 53(7):e14062. PubMed ID: 33887077
[TBL] [Abstract][Full Text] [Related]
6. Former Abusers of Anabolic Androgenic Steroids Exhibit Decreased Testosterone Levels and Hypogonadal Symptoms Years after Cessation: A Case-Control Study.
Rasmussen JJ; Selmer C; Østergren PB; Pedersen KB; Schou M; Gustafsson F; Faber J; Juul A; Kistorp C
PLoS One; 2016; 11(8):e0161208. PubMed ID: 27532478
[TBL] [Abstract][Full Text] [Related]
7. A qualitative assessment of anabolic-androgenic steroid use among gym users in Jordan: motives, perception, and safety.
Izzat N; Abu-Farha R; Harahsheh MM; Thiab S
Int J Legal Med; 2023 Sep; 137(5):1421-1430. PubMed ID: 37355480
[TBL] [Abstract][Full Text] [Related]
8. Factors predicting normalization of reproductive hormones after cessation of anabolic-androgenic steroids in men: a single center retrospective study.
Grant B; Campbell J; Pradeep A; Burns AD; Bassett P; Abbara A; Saket P; Minhas S; Dhillo WS; McVeigh J; Bhasin S; Jayasena CN
Eur J Endocrinol; 2023 Dec; 189(6):601-610. PubMed ID: 38102386
[TBL] [Abstract][Full Text] [Related]
9. The awareness and experience of healthcare providers with the use of anabolic androgenic steroids by gym users.
Izzat N; Abu-Farha R; Al-Mestarihi E; Alzoubi KH
Int J Legal Med; 2023 Nov; 137(6):1705-1711. PubMed ID: 37624373
[TBL] [Abstract][Full Text] [Related]
10. Body Image Disorders and Anabolic Steroid Withdrawal Hypogonadism in Men.
Pope HG; Kanayama G
Endocrinol Metab Clin North Am; 2022 Mar; 51(1):205-216. PubMed ID: 35216717
[TBL] [Abstract][Full Text] [Related]
11. Health service engagement, side effects and concerns among men with anabolic-androgenic steroid use: a cross-sectional Norwegian study.
Henriksen HCB; Havnes IA; Jørstad ML; Bjørnebekk A
Subst Abuse Treat Prev Policy; 2023 Apr; 18(1):19. PubMed ID: 37013635
[TBL] [Abstract][Full Text] [Related]
12. Impact of anabolic androgenic steroids on male sexual and reproductive function: a systematic review.
Esposito M; Salerno M; Calvano G; Agliozzo R; Ficarra V; Sessa F; Favilla V; Cimino S; Pomara C
Panminerva Med; 2023 Mar; 65(1):43-50. PubMed ID: 35146992
[TBL] [Abstract][Full Text] [Related]
13. [Peculiarity of recovery of the hypothalamic-pituitary-gonadal (hpg) axis, in men after using androgenic anabolic steroids].
Lykhonosov MP; Babenko AY; Makarin VA; Fedotov YN
Probl Endokrinol (Mosk); 2020 Aug; 66(1):104-112. PubMed ID: 33351319
[TBL] [Abstract][Full Text] [Related]
14. Knowledge, attitudes and use of anabolic-androgenic steroids among male gym users: A community based survey in Riyadh, Saudi Arabia.
Alharbi FF; Gamaleddin I; Alharbi SF; Almodayfer O; Allohidan F; Alghobain M; Arafah A; Al-Surimi K
Saudi Pharm J; 2019 Feb; 27(2):254-263. PubMed ID: 30766438
[TBL] [Abstract][Full Text] [Related]
15. Use, Misuse and Abuse of Testosterone and Other Androgens.
Linhares BL; Miranda EP; Cintra AR; Reges R; Torres LO
Sex Med Rev; 2022 Oct; 10(4):583-595. PubMed ID: 37051948
[TBL] [Abstract][Full Text] [Related]
16. Physical appearance concerns are uniquely associated with the severity of steroid dependence and depression in anabolic-androgenic steroid users.
Griffiths S; Jacka B; Degenhardt L; Murray SB; Larance B
Drug Alcohol Rev; 2018 Jul; 37(5):664-670. PubMed ID: 29484740
[TBL] [Abstract][Full Text] [Related]
17. The Central Effects of Androgenic-anabolic Steroid Use.
Mędraś M; Brona A; Jóźków P
J Addict Med; 2018; 12(3):184-192. PubMed ID: 29470183
[TBL] [Abstract][Full Text] [Related]
18. Common symptoms associated with usage and cessation of anabolic androgenic steroids in men.
Sharma A; Grant B; Islam H; Kapoor A; Pradeep A; Jayasena CN
Best Pract Res Clin Endocrinol Metab; 2022 Sep; 36(5):101691. PubMed ID: 35999138
[TBL] [Abstract][Full Text] [Related]
19. Anabolic-androgenic steroids are linked to depression and anxiety in male bodybuilders: the hidden psychogenic side of anabolic androgenic steroids.
Karagun B; Altug S
Ann Med; 2024 Dec; 56(1):2337717. PubMed ID: 38590148
[TBL] [Abstract][Full Text] [Related]
20. Anabolic Androgenic Steroid Use Patterns and Steroid Use Disorders in a Sample of Male Gym Visitors.
de Zeeuw TI; Brunt TM; van Amsterdam J; van de Ven K; van den Brink W
Eur Addict Res; 2023; 29(2):99-108. PubMed ID: 36731448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]